Trials / Unknown
UnknownNCT04274608
Intra-gastric Fundal and Body Injection of Botulinum Toxin A for Weight Loss, a Randomized Controlled Trial
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Tan Tock Seng Hospital · Academic / Other
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized controlled trial to compare intra-gastric injection of Botulinum Toxin A (Botox; Allergan Inc. Irvine, Ca, USA) against non-surgical management for obesity (i.e. exercise/diet). Our hypothesis is that intra-gastric injection of Botox into the fundus and body of the stomach will result in greater weight loss than just exercise and diet alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum toxin type A | Intragastric injection of Botulinum toxin type A |
| BEHAVIORAL | Weight Management Program | 12 week weight management program |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2021-07-01
- Completion
- 2022-07-01
- First posted
- 2020-02-18
- Last updated
- 2020-02-18
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT04274608. Inclusion in this directory is not an endorsement.